Q4 2026 Yatharth Hospital & Trauma Care Services Ltd Earnings Call Transcript
Key Points
- Yatharth Hospital and Trauma Care Services Ltd (NSE:YATHARTH) reported a consolidated revenue growth of 36% year-over-year, reaching approximately INR12,072 million.
- The company achieved a 30% year-over-year increase in EBITDA, amounting to INR2,921 million, reflecting strong operational execution.
- Newly operational hospitals in New Delhi and Faridabad contributed approximately 11% to revenue in Q4 FY26, showcasing rapid ramp-up and strong performance.
- The company successfully integrated a 250-bed hospital in Agra, achieving a monthly revenue run rate of approximately INR7 crores with double-digit EBITDA margins.
- Yatharth Hospital and Trauma Care Services Ltd (NSE:YATHARTH) has a robust cash position of INR3,931 million, providing financial flexibility for future growth opportunities.
- The company faces significant interest costs due to loans taken for recent acquisitions, impacting financial performance.
- Occupancy rates at some new hospitals, such as the Faridabad Sector 20 facility, remain relatively low, indicating potential underutilization.
- The ARPOB (Average Revenue Per Occupied Bed) for the Jhansi hospital is lower than the company average, affecting overall revenue contribution.
- There is a notable increase in debt levels, with the current debt standing at INR230 crores, which may impact future financial stability.
- The company is experiencing challenges in maintaining consistent ARPOB growth across all facilities, with some hospitals reporting lower-than-expected figures.
Ladies and gentlemen, good day, and welcome to Yatharth Hospital and Trauma Care Services Limited Q4 FY26 earnings conference call hosted by Antique Stockbroking Limited. Let me draw your attention to the fact that on this call, discussions will include certain forward-looking statements, which are predictions, projections or other estimates about the future events. These estimates reflect management's current expectations about the future performance of the company.
Please note that these estimates involve several risks and uncertainties that could cause company's actual results to differ materially from what is expressed or implied. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Sumit Gupta, Senior VP, Institutional Equity Research, Healthcare from Antique Stock Broking Limited. Thank you, and over to you, Mr. Gupta.
Thank you. Good day, everyone. On behalf of Antique Stock Broking, we welcome you all to the Q4 and FY26
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
